In this issue: New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions.
Vascular endothelial growth factor (vegf) is a key factor in the normal and tumor microenvironment regulating angiogenesis.
In this issue: New treatment for TB; safety of dabigatran; quality of antidepressants; systolic hypertension treatment; and FDA actions.
The authors performed a randomized, double-blind study to compare the effects of progestin-only and combined hormonal contraceptive pills on rates of breastfeeding continuation in postpartum women.
How often are we asked whether a patient who has had severe nausea and vomiting in early pregnancy has a greater chance of adverse outcome in her pregnancy?
Heffron et al conducted a secondary analysis of two longitudinal studies (2004-2010) performed in Africa.
